WallStSmart

Bakkt Holdings Inc (BKKT)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Bakkt Holdings Inc generates 802% more annual revenue ($2.34B vs $258.90M). BKKT leads profitability with a -4.6% profit margin vs -15.5%. ZEPP earns a higher WallStSmart Score of 41/100 (D).

BKKT

Avoid

27

out of 100

Grade: F

Growth: 5.3Profit: 2.0Value: 5.0Quality: 5.0

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for BKKT.

ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BKKT1 strengths · Avg: 8.0/10
Price/BookValuation
1.9x8/10

Reasonable price relative to book value

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

BKKT4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$269.86M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-111.2%2/10

ROE of -111.2% — below average capital efficiency

Revenue GrowthGrowth
-83.4%2/10

Revenue declined 83.4%

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : BKKT

The strongest argument for BKKT centers on Price/Book.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : BKKT

The primary concerns for BKKT are EPS Growth, Market Cap, Return on Equity.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

BKKT profiles as a turnaround stock while ZEPP is a hypergrowth play — different risk/reward profiles.

BKKT carries more volatility with a beta of 6.05 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor SOFTWARE - INFRASTRUCTURE industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ZEPP scores higher overall (41/100 vs 27/100) and 43.0% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Bakkt Holdings Inc

TECHNOLOGY · SOFTWARE - INFRASTRUCTURE · USA

Bakkt Holdings Inc. is a prominent digital asset platform focused on bridging the gap between cryptocurrencies and traditional financial transactions for consumers and enterprises. Through innovative payment solutions and loyalty programs, Bakkt enhances the user experience while driving the adoption of blockchain technologies. With a solid technological foundation and strategic partnerships, the company is well-positioned to influence the integration of digital currencies into the mainstream financial ecosystem, significantly contributing to the growth of the fintech sector.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?